Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 6,589-6,600 of 10,612

Drug study icon

CompletedNCT00235729

Lofexidine for Inpatient Opiate Detox

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: US Department of Veterans Affairs
Condition: Addiction

Drug study icon

CompletedNCT04056182

Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Addiction

Behavioral study icon

CompletedNCT05484258

Loneliness and Health Outcomes in the High Need Population

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Addiction, Depression, ...BehavioralOver 18 Years

Countries: United States
Sponsor: Vanderbilt University Medical Center
Condition: Addiction, Depression, ...

Drug study icon

WithdrawnNCT01584466

Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Study

This study was withdrawn in the United States. It focuses on schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Drug study icon

CompletedNCT00754208

Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 4 Years to 5 Years

Countries: United States
Sponsor: University of Nebraska
Condition: ADHD

Behavioral study icon

WithdrawnNCT04212065

Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 41 Years

Countries: United States
Sponsor: Ohio State University
Condition: Addiction

Behavioral study icon

Enrolling By InvitationNCT06164756

Long Term Follow Up KET-PD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralFrom 40 Years to 80 Years

Countries: United States
Sponsor: Yale University
Condition: Depression

Device study icon

TerminatedNCT03360942

Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, BipolarityDeviceFrom 18 Years to 70 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Depression, Bipolarity

Other study type icon

CompletedNCT00958061

Long Term Health Outcomes of Women Veterans' Service During the Vietnam Era

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, DepressionObservational

Countries: United States
Sponsor: VA Office of Research and Development
Condition: PTSD, Depression

Drug study icon

CompletedNCT00686933

Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: AbbVie (prior sponsor, Abbott)
Condition: ADHD

Drug study icon

CompletedNCT00857220

Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Sumitomo Pharma America, Inc.
Condition: ADHD

Drug study icon

CompletedNCT02203838

Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Indivior Inc.
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.